Parkinson, J. An Essay on the Shaking Palsy. London: Whittingham and Rowland. 1817.Google Scholar

Charcot, J. Lectures on Diseases of the Nervous System. London: The New Sydenham Society. 1877.Google Scholar

Gowers, W. A Manual of Disease of the Nervous System. Philadelphia: Blakiston. 1888.Google Scholar

Beiske, AG, Loge, JH, Rønningen, A, Svensson, E. Pain in Parkinson's disease: prevalence and characteristics. Pain 2009; 141: 173–7.CrossRefGoogle ScholarPubMed

Perez-Lloret, S, Rey, MV, Dellapina, E, et al. Emerging analgesic drugs for Parkinson's disease. Expert Opin Emerg Drugs 2012; 17: 157–71.CrossRefGoogle ScholarPubMed

Lee, MA, Walker, RW, Hildreth, TJ, Prentice, WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006; 32: 462–9.Google Scholar

Defazio, G, Berardelli, A, Fabbrini, G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case–control study. Arch Neurol 2008; 65: 1191–4.Google Scholar

O'sullivan, SS, Williams, DR, Gallagher, DA, et al. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008; 23: 101–6.Google Scholar

Burkey, AR, Carstens, E, Jasmin, L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 1999; 19: 4169–79.CrossRefGoogle ScholarPubMed

Barnes, CD, Fung, SJ, Adams, WL. Inhibitory effects of substantia nigra on impulse transmission from nociceptors. Pain 1979; 6: 207–15.Google Scholar

Chudler, EH, Dong, WK. The role of the basal ganglia in nociception and pain. Pain 1995; 60: 3–38.Google Scholar

Honey, CR, Stoessl, AJ, Tsui, JK, Schulzer, M, Calne, DB. Unilateral pallidotomy for reduction of parkinsonian pain. J Neurosurg 1999; 91: 198–201.CrossRefGoogle ScholarPubMed

Loher, TJ, Burgunder, JM, Weber, S, Sommerhalder, R, Krauss, JK. Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 395–9.Google Scholar

Fil, A, Cano-de-la-Cuerda, R, Muñoz-Hellín, E, et al. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord 2013; 19: 285–94; discussion 285.Google Scholar

Willis, WD, Westlund, KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997; 14: 2–31.CrossRefGoogle ScholarPubMed

Braak, H, Del Tredici, K, Rüb, U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197–211.Google Scholar

Scherder, E, Wolters, E, Polman, C, Sergeant, J, Swaab, D. Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systems. Neurosci Biobehav Rev 2005; 29: 1047–56.Google Scholar

Nolano, M, Provitera, V, Estraneo, A, et al. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. Brain 2008; 131: 1903–11.Google Scholar

Braak, H, Sastre, M, Bohl, E JR, de Vos, RAI, Del Tredici, K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421–9.Google Scholar

Barone, P. Neurotransmission in Parkinson's disease: beyond dopamine. Eur J Neurol 2010; 17: 364–76.Google Scholar

Millan, MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1–164.CrossRefGoogle ScholarPubMed

Juri, C, Rodriguez-Oroz, M, Obeso, JA. The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurolog Sci 2010; 289: 60–5.Google Scholar

Wood, PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8: 781–97.Google Scholar

Brefel-Courbon, C, Payoux, P, Thalamas, C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005; 20: 1557–63.Google Scholar

Djaldetti, R, Shifrin, A, Rogowski, Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171–5.CrossRefGoogle ScholarPubMed

Dellapina, E, Gerdelat-Mas, A, Ory-Magne, F, et al. Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2011; 26: 153–7.Google Scholar

Goetz, CG, Tanner, CM, Levy, M, Wilson, RS, Garron, DC. Pain in Parkinson's disease. Mov Disord 1986; 1: 45–9.Google Scholar

Nègre-Pagès, L, Regragui, W, Bouhassira, D, Grandjean, H, Rascol, O. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 2008; 23: 1361–9.CrossRefGoogle ScholarPubMed

Tinazzi, M, Del Vesco, C, Fincati, E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 822–5.CrossRefGoogle ScholarPubMed

Rollman, GB, Lautenbacher, S. Sex differences in musculoskeletal pain. Clin J Pain 2001; 17: 20–4.Google Scholar

Scott, B, Borgman, A, Engler, H, Johnels, B, Aquilonius, SM. Gender differences in Parkinson's disease symptom profile. Acta Neurol Scand 2000; 102: 37–43.Google Scholar

Hanagasi, HA, Akat, S, Gurvit, H, Yazici, J, Emre, M. Pain is common in Parkinson's disease. Clin Neurol Neurosurg 2011; 113: 11–13.Google Scholar

Ehrt, U, Larsen, JP, Aarsland, D. Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 2009; 17: 269–75.CrossRefGoogle ScholarPubMed

Goetz, CG, Wilson, RS, Tanner, CM, Garron, DC. Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol 1987; 45: 345–7.Google ScholarPubMed

Snider, SR, Fahn, S, Isgreen, WP, Cote, LJ. Primary sensory symptoms in parkinsonism. Neurology 1976; 26: 423–9.Google Scholar

Ford, B. Pain in Parkinson's disease. Mov Disord 2010; 25( Suppl. 1): S98–103.CrossRefGoogle ScholarPubMed

Del Sorbo, F, Albanese, A. Clinical management of pain and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2012; 18 (Suppl. 1): S233–6.CrossRefGoogle ScholarPubMed

Bissonnette, B. Pseudorheumatoid deformity of the feet associated with parkinsonism. J Rheumatol 1986; 13: 825–6.Google Scholar

Santos-García, D, Abella-Corral, J, Aneiros-Díaz, Á, et al. [Pain in Parkinson's disease: prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden]. Rev Neurol 2011; 52: 385–93 (in Spanish).Google Scholar

Duvoisin, RC, Marsden, CD. Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry 1975; 38: 787–93.Google Scholar

Broetz, D, Eichner, M, Gasser, T, Weller, M, Steinbach, JP. Radicular and nonradicular back pain in Parkinson's disease: a controlled study. Mov Disord 2007; 22: 853–6.CrossRefGoogle ScholarPubMed

Schnitzer, TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol 2006; 25 (Suppl. 1): S22–9.Google Scholar

Tolosa, E, Compta, Y. Dystonia in Parkinson's disease. J Neurol 2006; 253 (Suppl. VII): 7–13.Google Scholar

Kidron, D, Melamed, . Forms of dystonia in patients with Parkinson's disease. Neurology 1987; 37: 1009–11.Google Scholar

Sophie, M, Ford, B. Management of pain in Parkinson's disease. CNS Drugs 2012; 26: 937–48.Google Scholar

Karlsborg, M, Korbo, L, Regeur, L, Glad, A. Duodopa pump treatment in patients with advanced Parkinson's disease. Dan Med Bull 2010; 57: A4155.Google Scholar

Lees, AJ. Dopamine agonists in Parkinson's disease: a look at apomorphine. Fundam Clin Pharmacol 1993; 7: 121–8.Google Scholar

Sanford, M, Scott, LJ. Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease. CNS Drugs 2011; 25: 699–719.CrossRefGoogle ScholarPubMed

Stocchi, F, Ruggieri, S, Antonini, A, et al. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration. J Neural Transm Suppl 1988; 27: 27–33.Google Scholar

Cordivari, C, Misra, VP, Catania, S, Lees, AJ. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord 2001; 16: 907–13.CrossRefGoogle ScholarPubMed

Pacchetti, C, Albani, G, Martignoni, E, et al. “Off” painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 1995; 10: 333–6.Google Scholar

Kim, HJ, Jeon, BS, Paek, SH. Effect of deep brain stimulation on pain in Parkinson disease. J Neurolog Sci 2011; 310: 251–5.Google Scholar

Oshima, H, Katayama, Y, Morishita, T, et al. Subthalamic nucleus stimulation for attenuation of pain related to Parkinson disease. J Neurosurg 2012; 116: 99–106.CrossRefGoogle ScholarPubMed

Witjas, T, Kaphan, E, Régis, J, et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007; 22: 1729–34.Google Scholar

Thomas, A, Iacono, D, Luciano, AL, et al. Duration of amantadine benefit on dyskinesia of severe Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 141–3.Google ScholarPubMed

Metman, LV, Del Dotto, P, LePoole, K, et al. Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study. Arch Neurol 1999; 56: 1383–6.Google Scholar

Durif, F. Foot dystonia treatment by botulinum toxin injections in Parkinson disease: efficiency of injections made in extrinsic muscle (flexor digitorum longus muscle) compared to intrinsic muscle (flexor digitorum brevis or quadratus plantae muscles) (RBHP 2008). ClinicalTrials.gov, 2009; NCT00909883. Available from: http://clinicaltrials.gov/ct2/show/NCT00909883?term=botulinum+pain+parkinson's&rank=1.Google Scholar

Yucel, A, Yilmaz, O, Babaoglu, S, Acar, M, Degirmenci, B. Sonographic findings of the median nerve and prevalence of carpal tunnel syndrome in patients with Parkinson's disease. Eur J Radiol 2008; 67: 546–50.Google Scholar

Preston, DN, Grimes, JD. Radial compression neuropathy in advanced Parkinson's disease. Arch Neurol 1985; 42: 695–6.CrossRefGoogle ScholarPubMed

Kurlan, R, Baker, P, Miller, C, Shoulson, I. Severe compression neuropathy following sudden onset of parkinsonian immobility. Arch Neurol 1985; 42: 720.Google Scholar

Wasner, G, Deuschl, G. Pains in Parkinson disease – many syndromes under one umbrella. Nature reviews. Neurology 2012; 8: 284–94.Google Scholar

Shulman, LM, Minagar, A, Sharma, K, Weiner, WJ. Amantadine-induced peripheral neuropathy. Neurology 1999; 53: 1862–5.Google Scholar

Rajabally, YA, Martey, J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology 2011; 77: 1947–50.Google Scholar

Toth, C, Breithaupt, K, Ge, S, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 2010; 68: 28–36.CrossRefGoogle ScholarPubMed

Comella, CL, Goetz, CG. Akathisia in Parkinson's disease. Mov Disord 1994; 9: 545–9.Google Scholar

Krishnan, PR, Bhatia, M, Behari, M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003; 18: 181–5.Google Scholar

Ondo, WG, Vuong, KD, Jankovic, J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002; 59: 421–4.Google Scholar

Ford, B, Louis, ED, Greene, P, Fahn, S. Oral and genital pain syndromes in Parkinson's disease. Mov Disord 1996; 11: 421–6.Google Scholar

Schestatsky, P, Kumru, H, Valls-Solé, J, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 2007; 69: 2162–9.Google Scholar

Gierthmühlen, J, Arning, P, Binder, A, et al. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 2010; 25: 1195–202.Google Scholar

Allain, H, Schuck, S, Mauduit, N. Depression in Parkinson's disease. BMJ 2000; 320: 1287–8.Google Scholar

Djaldetti, R, Yust-Katz, S, Kolianov, V, Melamed, E, Dabby, R. The effect of duloxetine on primary pain symptoms in Parkinson disease. Clin Neuropharmacol 30: 201–5.Google Scholar

Goodwin, VA, Richards, SH, Taylor, RS, Taylor, AH, Campbell, JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2008; 23: 631–40.Google Scholar

Reuter, I, Mehnert, S, Leone, P, et al. Effects of a flexibility and relaxation programme, walking, and nordic walking on Parkinson's disease. J Aging Res 2011; 2011: 232473.Google Scholar

Ferry, P, Johnson, M, Wallis, P. Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease. Postgrad Med J 2002; 78: 612–4.Google Scholar

Kim, SR, Lee, TY, Kim, MS, Lee, MC, Chung, SJ. Use of complementary and alternative medicine by Korean patients with Parkinson's disease. Clin Neurol Neurosurg 2009; 111: 156–60.Google Scholar

Cristian, A, Katz, M, Cutrone, E, Walker, RH. Evaluation of acupuncture in the treatment of Parkinson's disease: a double-blind pilot study. Mov Disord 2005; 20: 1185–8.Google Scholar

Shulman, LM, Wen, X, Weiner, WJ, et al. Acupuncture therapy for the symptoms of Parkinson's disease. Mov Disord 2002; 17: 799–802.Google Scholar

Kim, HJ, Paek, SH, Kim, JY, et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 2008; 255: 1889–94.Google Scholar

Lomarev, MP, Kanchana, S, Bara-Jimenez, W, et al. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006; 21: 325–31.Google Scholar

Kodama, M, Kasahara, T, Hyodo, M, et al. Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease. Am J Phys Med Rehabil 2011; 90: 150–5.Google Scholar

Bestmann, S, Baudewig, J, Siebner, HR, Rothwell, JC, Frahm, J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 2004; 19: 1950–62.Google Scholar

Maarrawi, J, Peyron, R, Mertens, P, et al. Motor cortex stimulation for pain control induces changes in the endogenous opioid system. Neurology 2007; 69: 827–34.Google Scholar

Gabis, L, Shklar, B, Baruch, YK, et al. Pain reduction using transcranial electrostimulation: a double blind “active placebo” controlled trial. J Rehabil Med 2009; 41: 256–61.Google Scholar

Rintala, DH, Tan, G, Willson, P, Bryant, MS, Lai, ECH. Feasibility of using cranial electrotherapy stimulation for pain in persons with Parkinson's disease. Parkinsons Dis 2010; 2010: 569154.Google ScholarPubMed

Jankovic, J, Leder, S, Warner, D, Schwartz, K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991; 41: 1088–91.Google Scholar

Morren, JA, Lugo, R, Gálvez-jiménez, N. EMG findings in Parkinson's disease patients with peripheral nerve injuries. In: The Movement Disorder Society's 15th International Congress of Parkinson's Disease and Movement Disorders, Toronto, Abstact 809, 2011.Google Scholar

Toth, C, Brown, MS, Furtado, S, Suchowersky, O, Zochodne, D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008; 23: 1850–9.Google Scholar

Müller, T, van Laar, T, Cornblath, DR, et al. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. Parkinsonism Relat Disord 2013; 19: 501–7; discussion 501.Google Scholar

Urban, PP, Wellach, I, Faiss, S, et al. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010; 25: 1748–52.Google Scholar

Manca, D, Cossu, G, Murgia, D, et al. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy. Mov Disord 2009; 24: 2293–4.Google Scholar

Antonini, A, Isaias, IU, Canesi, M, et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 2007; 22: 1145–9.CrossRefGoogle ScholarPubMed

Klostermann, F, Jugel, C, Müller, T, Marzinzik, F. Malnutritional neuropathy under intestinal levodopa infusion. J Neural Transm 2012; 119: 369–72.Google Scholar

Meppelink, AM, Nyman, R, van Laar, T, et al. Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease. Mov Disord 2011; 26: 331–4.Google Scholar

van Hilten, JJ, Weggeman, M, van der Velde, EA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm 1993; 5: 235–44.Google Scholar

Quittenbaum, BH, Grahn, B. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. Parkinsonism Relat Disord 2004; 10: 129–36.Google Scholar

Caap-Ahlgren, M, Dehlin, O. Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home. Arch Gerontol Geriatr 2001; 32: 23–33.Google Scholar

Politis, M, Wu, K, Molloy, S, et al. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010; 25: 1646–51.Google Scholar